🇺🇸 FDA
Pipeline program

SODIUM CHLORIDE SOLUTION 0.9%

TG1-CL-201

Phase 2 small_molecule active

Quick answer

SODIUM CHLORIDE SOLUTION 0.9% for Acute Ischemic Stroke is a Phase 2 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Acute Ischemic Stroke
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials